Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose naltrexone and gabapentin for pain in HIV-infected persons with alcohol problems
NCT04052139Phase 2Completed
- Sponsor
- Boston Medical Center
- Start
- Jan 2021
- Primary completion
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of naltrexone, gabapentin in chronic pain, alcohol use disorder (AUD), sponsored by Boston Medical Center. Started Jan 2021; status: completed.
02
Drugs
naltrexonegabapentin
03
Conditions
chronic painalcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT04052139.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04052139.